3.91
+3.17%
Close of 9 Nov 2026, in SEK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About OssDsign
Its shares trade on Nasdaq Stockholm under the ticker OSSD.ST. It has been listed since 24 May 2019. In the fiscal year to 31 December 2025, it reported revenue of SEK 180.2m and a net loss of SEK 51.0m. At that date it held total assets of SEK 397.9m and shareholders' equity of SEK 310.0m.
OssDsign AB is a holding company, which engages in the development and sales of medical technology products. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2019-05-24. The company aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The firm uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The firm's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 24 May 2019
- Website
- ossdsign.com ↗
Leadership
Pay as last reported
- Mr. Simon CartmellIndependent Chairman of the BoardSEK 490,000
- Mr. Anders LundqvistChief Executive Officer, since 2015SEK 2.2m
- Mr. Anders SvenssonChief Financial Officer
- Ms. Kajsa BjorklundDirector of Technical Operations, since 2018
- Mr. Rick ThomasVice President Commercial Operations, since 2016
- Mr. Henrik HjortDirector of Marketing & Business Development, since 2016
- Mr. Ulrik BirgerssonDirector Clinical Engineering, since 2016
- Ms. Malin KylbergQuality Assurance Director, since 2017
- Ms. Jill SchiaparelliDirector
- Mr. Tomas BlomquistIndependent Director
- Dr. Christer FahraeusIndependent Director
- Mr. David JernIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- OssDsign AB develops proprietary bioceramic technologies for bone healing and skull surgery implants.
- Craniomosaic is a leading implant for skull defect repair used by neurosurgeons.
- The company focuses on material compositions and manufacturing processes based on bioceramic solutions.
Weaknesses
- OssDsign AB's business is limited to skull surgery and facial bone augmentation segments.
- The company has no presence in other medical technology markets beyond bone healing.
- Craniomosaic is its sole primary product with limited diversification.
Opportunities
- OssDsign AB can expand bioceramic applications into other bone healing areas.
- The growing demand for craniofacial surgery solutions presents new market opportunities.
- The company may develop additional products for facial bone augmentation segments.
Threats
- OssDsign AB faces competition from established medical device companies in the Health Care sector.
- The company's reliance on a single product line poses market risk.
- Regulatory changes in medical technology could impact product approvals.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.